Signal · indexed from UN News
UN News
Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
Provenance
The notice above is the public record. Signing in adds the analysis: saved views and alerts on searches like this one, workflow and pipeline, exports and full workspace tooling.
| Field | How we know | State | Confidence |
|---|---|---|---|
| Publication date | Official API or feed | Data quality: Source-backed | 100 |
States describe GLODA's confidence in its own fields, never a judgement on the notice or its parties. Methodology
GLODA indexes publicly available notices from the funders and organizations it covers. We are an independent platform and are not affiliated with, or endorsed by, any indexed organization.
© 2026 Global Development Alliance LLC. All rights reserved.